Last reviewed · How we verify
omega-3 fatty acids (fish oil)
Omega-3 fatty acids (fish oil) help reduce inflammation and improve heart health by modulating the body's response to fatty acids.
Omega-3 fatty acids (fish oil) help reduce inflammation and improve heart health by modulating the body's response to fatty acids. Used for Hypertriglyceridemia, Cardiac arrhythmias, Atrial fibrillation for stroke prevention.
At a glance
| Generic name | omega-3 fatty acids (fish oil) |
|---|---|
| Also known as | Fish oil, n-3 fatty acids, Omacor, fish oil, Omacor, 1 capsule a day. |
| Sponsor | Brigham and Women's Hospital |
| Drug class | Fatty acid |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | Phase 3 |
Mechanism of action
Omega-3 fatty acids, particularly EPA and DHA, have anti-inflammatory properties that help reduce the risk of heart disease by lowering triglycerides, reducing blood pressure, and preventing blood clots. They also have anti-inflammatory effects on the body, which may help alleviate symptoms of conditions such as rheumatoid arthritis.
Approved indications
- Hypertriglyceridemia
- Cardiac arrhythmias
- Atrial fibrillation for stroke prevention
Common side effects
- Nausea
- Diarrhea
- Fishy aftertaste
Key clinical trials
- FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM) (PHASE2)
- Heart & Health Study (NA)
- A Clinical Trial Via Telepsychiatry of Treatments for the Management of Emotional Dysregulation in Youth (PHASE4)
- Can People Achieve a Target Omega-3 Index by Following a Personalized Omega-3 Dosing Regimen? (NA)
- Effect of a Parenteral Emulsion With Omega3 on Neonates With PPHN and CDH (PHASE2)
- Impact of an Omega-3 Enriched Oral Nutritional Supplement on Improving Surgical Outcomes in Patients With Peritoneal Carcinomatosis Undergoing Cytoreductive Surgery (NA)
- Pharmacokinetic Study of Eicosapentaenoic Acid (EPA) and Calcium L-5-Methyltetrahydrofolate (L-5-MTHF) After Administration of CreNeuroS® CNS Fish Oil Plus Softgels in Healthy Subjects Under Fasting Conditions (NA)
- Preoperative Fish Oil PN and Prognosis After Constipation Surgery
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- omega-3 fatty acids (fish oil) CI brief — competitive landscape report
- omega-3 fatty acids (fish oil) updates RSS · CI watch RSS
- Brigham and Women's Hospital portfolio CI